查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1495433

西拉普利市场：按配方、形式、应用、分销管道划分 - 全球预测，2024-2030 年

Cilazapril Market by Formulation (Cilazapril Hydrochloride, Cilazapril Monohydrate), Form (Capsules, Tablets), Application, Distribution Channel - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年西拉普利市场规模为2.4002亿美元，2024年将达2.5157亿美元，2030年将达3.3938亿美元，复合年增长率为5.07%。

西拉普利是血管收缩素转化酵素(ACE) 抑制剂类药物中的一种，主要用于治疗高血压和某些类型的心臟衰竭。透过扩张血管，西拉普利可以降低血压，减轻心臟压力，并预防中风、心臟病和肾臟损伤。西拉普利的重要性在于其治疗这些心血管疾病的有效性和能力，帮助患者维持更好的生活品质。作为心血管疾病管理的关键组成部分，西拉普利透过减缓潜在危及生命的症状的进展来支持长期健康结果。西拉普利的全球市场主要是由越来越多的被诊断出患有高血压和其他心臟相关疾病的患者所推动的。作为一种 ACE 抑制剂，西拉普利在控制高血压和预防潜在的心血管併发症方面极为重要。患者数量的增加是一个关键的成长要素，因为它直接转化为对有效治疗方案的需求增加。然而，与西拉普利相关的严格的政府法规和产品案例是製造商面临的主要挑战。此外，持续的投资和对研发的关注可能会导致西拉普利的创新配方，从而提高疗效或减少副作用。这些进步可以改善患者的治疗效果和对治疗方法的依从性，并扩大药物的适销性和患者的可接受性。

主要市场统计
基准年[2023] 24002万美元
预测年份 [2024] 25157万美元
预测年份 [2030] 33938万美元
复合年增长率（%） 5.07%

区域洞察

在美国，尤其是美国和加拿大，西拉普利的需求与高血压和心血管疾病的流行密切相关。两国都有完善的医疗体系和高度的慢性病管理意识。然而，患者偏好因素和严格的监管标准影响着西拉普利的市场动态。在美国，美国心臟协会（AHA）等组织经常更新治疗指南，这可能会影响西拉普利的使用。在欧盟（EU），许多国家已经实现了统一的医疗保健和全民健保系统，导致对西拉普利的需求稳定。欧洲药品管理局 (EMA) 负责监管市场并确保患者的高度安全。最近的趋势集中在循环系统研究上，直接影响西拉普利的使用和发展。然而，中东和非洲的情况却截然不同。虽然医疗支出较高的海湾国家显示出市场成长潜力，但非洲部分地区需要更多的医疗基础设施并存在负担能力问题。此外，亚太地区是一个多元化的地区，医疗保健和经济水平各不相同。包括日本在内的国家人口老化增加了对有效高血压管理解决方案的需求，使日本成为西拉普利的重要市场。先进的医疗基础设施和当地指南强烈影响西拉普利的使用。由于生活方式的改变，人口众多的中国和印度的慢性病正在迅速增加。中国最近的医疗改革和印度不断增加的医疗支出显示了潜在的市场成长。投资主要旨在扩大医疗保健和意识提升计划的覆盖范围，这可以促进西拉普利的吸收。

FPNV定位矩阵

FPNV 定位矩阵对于评估西拉普利市场供应商的定位至关重要。此矩阵提供了对供应商的全面评估，并检查了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对西拉普利市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他关键指标。此外，该分析还提供了对该细分市场竞争力的宝贵见解，包括研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对西拉普利当前市场地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行概述

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 高血压和心臟病的发生率增加
      • 各国人口老化进展
    • 抑制因素
      • 与西拉普利相关的产品召回和副作用
    • 机会
      • 增加医疗保健方面的资金和改善基础设施
      • 联合治疗以增强药物疗效
    • 任务
      • 替代治疗方法的可用性
  • 市场区隔分析
    • 製剂：大量使用盐酸西拉普利製剂增加药物溶解度和稳定性
    • 用途：扩大西拉普利药物的用量，以降低高血压、预防心臟病和肾臟问题
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章 西拉普利市场：依配方分类

  • 介绍
  • 盐酸西拉普利
  • 西拉普利一水化合物

第七章 西拉普利市场：依形式

  • 介绍
  • 胶囊
  • 锭剂

第八章西拉普利市场：依应用分类

  • 介绍
  • 心臟衰竭管理
  • 高血压管理

第九章西拉普利市场：依通路分类

  • 介绍
  • 医院药房
  • 线下零售药局
  • 网路药房

第十章 西拉普利美洲市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太西拉普利市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 西拉普利欧洲、中东和非洲市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
    • Lupin 获得美国FDA核准西拉普利非专利
  • 战略分析和建议

第14章竞争组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-7949F05838FE

[184 Pages Report] The Cilazapril Market size was estimated at USD 240.02 million in 2023 and expected to reach USD 251.57 million in 2024, at a CAGR 5.07% to reach USD 339.38 million by 2030.

Cilazapril is a medication classified under the group of drugs called angiotensin-converting enzyme (ACE) inhibitors, which are primarily used to treat hypertension (high blood pressure) and certain types of heart failure. By dilating the blood vessels, cilazapril helps to reduce blood pressure and reduce the workload on the heart, thus preventing strokes, heart attacks, and kidney problems. Its importance lies in its efficacy and ability to manage these cardiovascular conditions, helping patients maintain a better quality of life. Cilazapril supports long-term health outcomes by curbing the progression of potentially life-threatening conditions as a vital component in cardiovascular disease management. The global market for cilazapril is primarily driven by the rising number of individuals diagnosed with hypertension and other heart-related conditions. Cilazapril, as an ACE inhibitor, is crucial in managing high blood pressure, thereby preventing potential cardiovascular complications. This increasing patient base is a significant growth factor as it directly correlates with the heightened demand for effective treatment options. However, strict government regulations and cases of product recalls associated with cilazapril are significant challenges faced by the manufacturers. Moreover, continuous investment and focus on research and development can lead to innovative formulations of cilazapril that offer improved efficacy or reduced side effects. Such advancements can enhance patient outcomes and adherence to treatment regimens, expanding the drug's marketability and patient acceptance.

KEY MARKET STATISTICS
Base Year [2023] USD 240.02 million
Estimated Year [2024] USD 251.57 million
Forecast Year [2030] USD 339.38 million
CAGR (%) 5.07%

Regional Insights

In America, particularly in the United States and Canada, the demand for cilazapril closely follows the prevalence of hypertension and cardiovascular diseases. Both countries have well-established healthcare systems and a high awareness of chronic disease management. However, patient preferential factors and rigorous regulatory standards influence cilazapril's market dynamics. The United States sees frequent updates in treatment guidelines by organizations such as the American Heart Association (AHA), which can affect cilazapril usage. In the European Union, a well-coordinated approach to healthcare and universal health coverage in many countries leads to a steady demand for cilazapril. The European Medicines Agency (EMA) regulates the market, ensuring a high standard of patient safety. Recent investments have focused on cardiovascular research, which has directly impacted cilazapril's usage and development. The Middle East and Africa, however, present a contrasting scenario. While some Gulf nations with high healthcare spending show potential for market growth, parts of Africa need more healthcare infrastructure and affordability issues. Moreover, Asia Pacific is a diverse region with varying healthcare access and economic levels. In countries including Japan, an aging population has heightened the need for effective hypertension management solutions, making Japan a significant market for cilazapril. Advanced healthcare infrastructure and local guidelines strongly influence cilazapril use here. China and India, with their massive populations, are witnessing a surge in chronic diseases due to lifestyle changes. China's recent healthcare reforms and India's growing healthcare expenditure indicate potential market growth. Investments are mainly directed towards expanding healthcare access and awareness programs, which could increase cilazapril adoption.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Cilazapril Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Increasing prevalence of hypertension and heart conditions
      • Growing geriatric population across countries
    • Market Restraints
      • Product recall and side effects associated with cilazapril
    • Market Opportunities
      • Enhanced funding and infrastructure improvements in healthcare
      • Combination therapies to enhance drug efficacy
    • Market Challenges
      • Availability of alternative treatments
  • Market Segmentation Analysis
    • Formulation: Extensive usage of cilazapril hydrochloride formulation to enhance medication's solubility and stability
    • Application: Expanding consumption of cilazapril drugs to lower high blood pressure, prevent heart attacks, and kidney problems
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Cilazapril Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Cilazapril Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Lupin Secures USFDA Approval for Generic Cilazapril

Lupin announced its achievement of receiving approval from the US Food and Drug Administration (USFDA) to market its generic version of the hypertension medication, Cilazapril. This authorization enables Lupin to offer a cost-effective alternative to the brand-name drug, primarily prescribed for treating high blood pressure. This development marks a significant milestone for Lupin and enhances its portfolio in the competitive generic drug market, potentially improving access to affordable healthcare options for patients managing hypertension in the United States. [Published On: 2024-01-14]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Cilazapril Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Cilazapril Market, highlighting leading vendors and their innovative profiles. These include Adooq Bioscience LLC, ANGLE BIO PHARMA, ApexBio Technology, Biorbyt Ltd., Biosynth Ltd., Cayman Chemical, Chemicea Limited, Enomark, He Ako Hiringa, Hetero Labs Limited, LGM Pharma, Manus Aktteva Biopharma LLP, Merck KGaA, MIMS Pte Ltd., and Santa Cruz Biotechnology, Inc..

Market Segmentation & Coverage

This research report categorizes the Cilazapril Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Formulation
    • Cilazapril Hydrochloride
    • Cilazapril Monohydrate
  • Form
    • Capsules
    • Tablets
  • Application
    • Heart Failure Management
    • Hypertension Management
  • Distribution Channel
    • Hospital Pharmacies
    • Offline Retail Pharmacies
    • Online Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of hypertension and heart conditions
      • 5.1.1.2. Growing geriatric population across countries
    • 5.1.2. Restraints
      • 5.1.2.1. Product recall and side effects associated with cilazapril
    • 5.1.3. Opportunities
      • 5.1.3.1. Enhanced funding and infrastructure improvements in healthcare
      • 5.1.3.2. Combination therapies to enhance drug efficacy
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternative treatments
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Formulation: Extensive usage of cilazapril hydrochloride formulation to enhance medication's solubility and stability
    • 5.2.2. Application: Expanding consumption of cilazapril drugs to lower high blood pressure, prevent heart attacks, and kidney problems
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Cilazapril Market, by Formulation

  • 6.1. Introduction
  • 6.2. Cilazapril Hydrochloride
  • 6.3. Cilazapril Monohydrate

7. Cilazapril Market, by Form

  • 7.1. Introduction
  • 7.2. Capsules
  • 7.3. Tablets

8. Cilazapril Market, by Application

  • 8.1. Introduction
  • 8.2. Heart Failure Management
  • 8.3. Hypertension Management

9. Cilazapril Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospital Pharmacies
  • 9.3. Offline Retail Pharmacies
  • 9.4. Online Pharmacies

10. Americas Cilazapril Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cilazapril Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cilazapril Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Lupin Secures USFDA Approval for Generic Cilazapril
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CILAZAPRIL MARKET RESEARCH PROCESS
  • FIGURE 2. CILAZAPRIL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CILAZAPRIL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CILAZAPRIL MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CILAZAPRIL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CILAZAPRIL MARKET DYNAMICS
  • FIGURE 7. GLOBAL CILAZAPRIL MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CILAZAPRIL MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CILAZAPRIL MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CILAZAPRIL MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CILAZAPRIL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CILAZAPRIL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES CILAZAPRIL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES CILAZAPRIL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. CILAZAPRIL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. CILAZAPRIL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CILAZAPRIL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CILAZAPRIL MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CILAZAPRIL MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CILAZAPRIL MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CILAZAPRIL MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CILAZAPRIL MARKET SIZE, BY CILAZAPRIL HYDROCHLORIDE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CILAZAPRIL MARKET SIZE, BY CILAZAPRIL HYDROCHLORIDE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CILAZAPRIL MARKET SIZE, BY CILAZAPRIL MONOHYDRATE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CILAZAPRIL MARKET SIZE, BY CILAZAPRIL MONOHYDRATE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CILAZAPRIL MARKET SIZE, BY CAPSULES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CILAZAPRIL MARKET SIZE, BY CAPSULES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CILAZAPRIL MARKET SIZE, BY TABLETS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CILAZAPRIL MARKET SIZE, BY TABLETS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CILAZAPRIL MARKET SIZE, BY HEART FAILURE MANAGEMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CILAZAPRIL MARKET SIZE, BY HEART FAILURE MANAGEMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CILAZAPRIL MARKET SIZE, BY HYPERTENSION MANAGEMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CILAZAPRIL MARKET SIZE, BY HYPERTENSION MANAGEMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CILAZAPRIL MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CILAZAPRIL MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CILAZAPRIL MARKET SIZE, BY OFFLINE RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CILAZAPRIL MARKET SIZE, BY OFFLINE RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CILAZAPRIL MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CILAZAPRIL MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS CILAZAPRIL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS CILAZAPRIL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 43. ARGENTINA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 44. ARGENTINA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 45. ARGENTINA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 46. ARGENTINA CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 51. BRAZIL CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 52. BRAZIL CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 53. BRAZIL CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 54. BRAZIL CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 57. BRAZIL CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 58. BRAZIL CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 59. CANADA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 60. CANADA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 61. CANADA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 62. CANADA CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 63. CANADA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 64. CANADA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 65. CANADA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 66. CANADA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 67. MEXICO CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 68. MEXICO CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 69. MEXICO CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 70. MEXICO CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 71. MEXICO CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 72. MEXICO CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 73. MEXICO CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 74. MEXICO CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 75. UNITED STATES CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 76. UNITED STATES CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 77. UNITED STATES CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 78. UNITED STATES CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 79. UNITED STATES CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 80. UNITED STATES CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 81. UNITED STATES CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 82. UNITED STATES CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 83. UNITED STATES CILAZAPRIL MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 84. UNITED STATES CILAZAPRIL MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC CILAZAPRIL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 96. AUSTRALIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 98. AUSTRALIA CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. AUSTRALIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 102. AUSTRALIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 103. CHINA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 104. CHINA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 105. CHINA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 106. CHINA CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 107. CHINA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 108. CHINA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 109. CHINA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 110. CHINA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 111. INDIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 112. INDIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 113. INDIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 114. INDIA CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 115. INDIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 116. INDIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 117. INDIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 118. INDIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 119. INDONESIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 120. INDONESIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 121. INDONESIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 122. INDONESIA CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 123. INDONESIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 124. INDONESIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 125. INDONESIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 126. INDONESIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 127. JAPAN CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 128. JAPAN CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 129. JAPAN CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 130. JAPAN CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 131. JAPAN CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 132. JAPAN CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 133. JAPAN CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 134. JAPAN CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 135. MALAYSIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 136. MALAYSIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 137. MALAYSIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 138. MALAYSIA CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 139. MALAYSIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 140. MALAYSIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 141. MALAYSIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 142. MALAYSIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 143. PHILIPPINES CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 144. PHILIPPINES CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 145. PHILIPPINES CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 146. PHILIPPINES CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 148. PHILIPPINES CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 150. PHILIPPINES CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 151. SINGAPORE CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 152. SINGAPORE CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 153. SINGAPORE CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 154. SINGAPORE CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 155. SINGAPORE CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. SINGAPORE CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. SINGAPORE CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 158. SINGAPORE CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 159. SOUTH KOREA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 160. SOUTH KOREA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 161. SOUTH KOREA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 162. SOUTH KOREA CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 164. SOUTH KOREA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 166. SOUTH KOREA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 167. TAIWAN CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 168. TAIWAN CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 169. TAIWAN CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 170. TAIWAN CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 171. TAIWAN CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 172. TAIWAN CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 173. TAIWAN CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 174. TAIWAN CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 175. THAILAND CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 176. THAILAND CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 177. THAILAND CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 178. THAILAND CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 179. THAILAND CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 180. THAILAND CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 181. THAILAND CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 182. THAILAND CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 183. VIETNAM CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 184. VIETNAM CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 185. VIETNAM CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 186. VIETNAM CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 187. VIETNAM CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. VIETNAM CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. VIETNAM CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 190. VIETNAM CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA CILAZAPRIL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 201. DENMARK CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 202. DENMARK CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 203. DENMARK CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 204. DENMARK CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 205. DENMARK CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 206. DENMARK CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 207. DENMARK CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 208. DENMARK CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 209. EGYPT CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 210. EGYPT CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 211. EGYPT CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 212. EGYPT CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 213. EGYPT CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 214. EGYPT CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 215. EGYPT CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 216. EGYPT CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 217. FINLAND CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 218. FINLAND CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 219. FINLAND CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 220. FINLAND CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 221. FINLAND CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 222. FINLAND CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 223. FINLAND CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 224. FINLAND CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 225. FRANCE CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 226. FRANCE CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 227. FRANCE CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 228. FRANCE CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 229. FRANCE CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 230. FRANCE CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 231. FRANCE CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 232. FRANCE CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 233. GERMANY CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 234. GERMANY CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 235. GERMANY CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 236. GERMANY CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 237. GERMANY CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 238. GERMANY CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 239. GERMANY CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 240. GERMANY CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 241. ISRAEL CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 242. ISRAEL CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 243. ISRAEL CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 244. ISRAEL CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 245. ISRAEL CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 246. ISRAEL CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 247. ISRAEL CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 248. ISRAEL CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 249. ITALY CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 250. ITALY CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 251. ITALY CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 252. ITALY CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 253. ITALY CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 254. ITALY CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 255. ITALY CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 256. ITALY CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 257. NETHERLANDS CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 258. NETHERLANDS CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 259. NETHERLANDS CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 260. NETHERLANDS CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 262. NETHERLANDS CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 264. NETHERLANDS CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 265. NIGERIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 266. NIGERIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 267. NIGERIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 268. NIGERIA CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 269. NIGERIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 270. NIGERIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 271. NIGERIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 272. NIGERIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 273. NORWAY CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 274. NORWAY CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 275. NORWAY CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 276. NORWAY CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 277. NORWAY CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 278. NORWAY CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 279. NORWAY CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 280. NORWAY CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 281. POLAND CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 282. POLAND CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 283. POLAND CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 284. POLAND CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 285. POLAND CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 286. POLAND CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 287. POLAND CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 288. POLAND CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 289. QATAR CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 290. QATAR CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 291. QATAR CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 292. QATAR CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 293. QATAR CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 294. QATAR CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 295. QATAR CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 296. QATAR CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 297. RUSSIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 298. RUSSIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 299. RUSSIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 300. RUSSIA CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 301. RUSSIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 302. RUSSIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 303. RUSSIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 304. RUSSIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 305. SAUDI ARABIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 306. SAUDI ARABIA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 307. SAUDI ARABIA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 308. SAUDI ARABIA CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 310. SAUDI ARABIA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 312. SAUDI ARABIA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 313. SOUTH AFRICA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 314. SOUTH AFRICA CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 315. SOUTH AFRICA CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 316. SOUTH AFRICA CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 318. SOUTH AFRICA CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 320. SOUTH AFRICA CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 321. SPAIN CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 322. SPAIN CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 323. SPAIN CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 324. SPAIN CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 325. SPAIN CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 326. SPAIN CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 327. SPAIN CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 328. SPAIN CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 329. SWEDEN CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 330. SWEDEN CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 331. SWEDEN CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 332. SWEDEN CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 333. SWEDEN CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 334. SWEDEN CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 335. SWEDEN CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 336. SWEDEN CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 337. SWITZERLAND CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 338. SWITZERLAND CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 339. SWITZERLAND CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 340. SWITZERLAND CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 341. SWITZERLAND CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 342. SWITZERLAND CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 344. SWITZERLAND CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 345. TURKEY CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 346. TURKEY CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 347. TURKEY CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 348. TURKEY CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 349. TURKEY CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 350. TURKEY CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 351. TURKEY CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 352. TURKEY CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 353. UNITED ARAB EMIRATES CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 354. UNITED ARAB EMIRATES CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 355. UNITED ARAB EMIRATES CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 356. UNITED ARAB EMIRATES CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 357. UNITED ARAB EMIRATES CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 358. UNITED ARAB EMIRATES CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 359. UNITED ARAB EMIRATES CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 360. UNITED ARAB EMIRATES CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 361. UNITED KINGDOM CILAZAPRIL MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 362. UNITED KINGDOM CILAZAPRIL MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 363. UNITED KINGDOM CILAZAPRIL MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 364. UNITED KINGDOM CILAZAPRIL MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 365. UNITED KINGDOM CILAZAPRIL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 366. UNITED KINGDOM CILAZAPRIL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 367. UNITED KINGDOM CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 368. UNITED KINGDOM CILAZAPRIL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 369. CILAZAPRIL MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 370. CILAZAPRIL MARKET, FPNV POSITIONING MATRIX, 2023